OSR Health, Inc. (OSRH) Form 8-K — Aug 19, 2026
OSR Health received a Nasdaq Staff Delisting Determination on August 19, 2026, and trading in its common stock (OSRH) and warrants (OSRHW) will be suspended at the opening of business on August 26, 2026, with Nasdaq set to file a Form 25-NSE to remove the securities from listing and registration. The delisting stems from the company's failure to regain compliance with the $1.00 minimum closing bid price requirement, despite an initial 180-day compliance period beginning September 5, 2025, and a second 180-day period through August 31, 2026 — regaining compliance would have required at least ten consecutive trading days at or above $1.00.
Key figures
- Public float shares
- approximately 18.5 million
- Shares traded aug17
- approximately 370 million
- Shares traded aug18
- approximately 145 million
- Intraday high aug18 usd
- 0.84
- Trading suspension date
- 2026-08-26
- Hearing request deadline
- 2026-08-26 4:00 PM ET
- Nasdaq volume rank aug17
- 1
- Nasdaq volume rank aug18
- 3
- Warrant exercise price usd
- 11.5
- Minimum bid requirement usd
- 1
- Second compliance period end
- 2026-08-31
- Initial compliance period end
- 2026-03-04
Price after filing
Close on the filing date to close N calendar days later (from $0.37). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.